Filing Details
- Accession Number:
- 0001179110-20-008367
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-17 17:32:50
- Reporting Period:
- 2020-07-15
- Accepted Time:
- 2020-07-17 17:32:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1650664 | Editas Medicine Inc. | EDIT | Biological Products, (No Disgnostic Substances) (2836) | 464097528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1682323 | Charles Albright | C/O Editas Medicine, Inc. 11 Hurley St. Cambridge MA 02141 | Evp/Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-07-15 | 3,000 | $32.22 | 28,373 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on May 15, 2020.
Billionaire Hedge Funds
